Assessment of Symptoms Control, Pulmonary Function and Related Quality of Life in Asthmatic Patients Treated with Extrafine Beclomethasone Dipropionate/Formoterol Fumarate 100/6 μg pMDI: Results of a Multicenter Observational Study in Romania (ALFRESCO Study)

References

• Oladunni E, Sumita S. The global impact of asthma in adult populations. Ann Glob Health. 2019;85(1):2.
   PubMed Web of Science ®Google Scholar
• Global Initiative for Asthma. Global strategy for asthma management and prevention; 2018. Available from: www.ginasthma.org. Accessed May 31, 2022.
   Google Scholar
• Ducharme FM, Ni Chroinin M, Greenstone I, Lasserson TJ. Addition of long-acting beta2-agonists to inhaled steroids versus higher dose inhaled steroids in adults and children with persistent asthma. Cochrane Database Syst Rev. 2010;4. doi:10.1002/14651858.CD005533.pub2
   Web of Science ®Google Scholar
• Bousquet J, Poli G, Acerbi D, et al. Systemic exposure and implications for lung deposition with an extra-fine hydrofluoroalkane beclometasone dipropionate/formoterol fixed combination. Clin Pharmacokinet. 2009;48(6):347–358. doi:10.2165/00003088-200948060-00001
   PubMed Web of Science ®Google Scholar
• De Backer W, Devolder A, Poli G, et al. Lung deposition of BDP/formoterol HFA pMDI in healthy volunteers, asthmatic, and COPD patients. J Aerosol Med Pulm Drug Deliv. 2010;23(3):137–148. doi:10.1089/jamp.2009.0772
   PubMed Web of Science ®Google Scholar
• Scichilone N, Battaglia S, Sorino C, et al. Effects of extra-fine inhaled beclomethasone/formoterol on both large and small airways in asthma. Eur J Allergy Clin Immunol. 2010;65(7):897–902. doi:10.1111/j.1398-9995.2009.02306.x
   Google Scholar
• Papi A, Corradi M, Pigeon-Francisco C, et al. Beclomethasone–formoterol as maintenance and reliever treatment in patients with asthma: a double-blind, randomized controlled trial. Respir Med. 2013;1(1):23–31.
   Web of Science ®Google Scholar
• Huchon G, Magnussen H, Chuchalin A, Dymek L, Gonod FB, Bousquet J. Lung function and asthma control with beclomethasone and formoterol in a single inhaler. Respir Med. 2009;103(1):41–49. doi:10.1016/j.rmed.2008.09.002
   PubMed Web of Science ®Google Scholar
• Bumbacea D, Panaitescu C, Bumbacea RS. Patient and physician perspectives on asthma and its therapy in Romania: results of a multicenter survey. Medicina. 2021;57(10):1089. doi:10.3390/medicina57101089
   PubMed Web of Science ®Google Scholar
• Partridge MR, van der Molen T, Myrseth SE, Busse WW. Attitudes and actions of asthma patients on regular maintenance therapy: the INSPIRE study. BMC Pulm Med. 2006;6(1):1–9. doi:10.1186/1471-2466-6-13
   PubMedGoogle Scholar
• Tuomisto LE, Ilmarinen P, Niemelä O, Haanpää J, Kankaanranta T, Kankaanranta H. A 12-year prognosis of adult-onset asthma: Seinäjoki adult asthma study. Respir Med. 2016;117:223–229. doi:10.1016/j.rmed.2016.06.017
   PubMed Web of Science ®Google Scholar
• Price D, Fletcher M, Van Der Molen T. Asthma control and management in 8000 European patients: the REcognise Asthma and LInk to Symptoms and Experience (REALISE) survey. NPJ Prim Care Respir Med. 2014;24(1):1–10. doi:10.1038/npjpcrm.2014.9
   Web of Science ®Google Scholar
• Olaguibel JM, Quirce S, Juliá B, et al. Measurement of asthma control according to global initiative for asthma guidelines: a comparison with the asthma control questionnaire. Respir Res. 2012;13(1):1–10. doi:10.1186/1465-9921-13-50
   PubMed Web of Science ®Google Scholar
• Vermeire PA, Rabe KF, Soriano JB, Maier WC. Asthma control and differences in management practices across seven European countries. Respir Med. 2002;96(3):142–149. doi:10.1053/rmed.2001.1241
   PubMed Web of Science ®Google Scholar
• Backer V, Bornemann M, Knudsen D, Ommen H. Scheduled asthma management in general practice generally improve asthma control in those who attend. Respir Med. 2012;106(5):635–641. doi:10.1016/j.rmed.2012.01.005
   PubMed Web of Science ®Google Scholar
• Global Initiative for Asthma. Global strategy for asthma management and prevention; 2022. Available from: www.ginasthma.org. Accessed May 31, 2022.
   Google Scholar
• Bateman ED, Reddel HK, Eriksson G, et al. Overall asthma control: the relationship between current control and future risk. J Allergy Clin Immunol. 2010;125(3):600–608. doi:10.1016/j.jaci.2009.11.033
   PubMed Web of Science ®Google Scholar
• Juniper EF, O’Byrne PM, Guyatt GH, Ferrie PJ, King DR. Development and validation of a questionnaire to measure asthma control. Eur Respir J. 1999;14(4):902–907. doi:10.1034/j.1399-3003.1999.14d29.x
   PubMed Web of Science ®Google Scholar
• Juniper EF, Bousquet J, Abetz L, Bateman ED; GOAL Committee. Identifying ‘well-controlled’ and ‘not well-controlled’ asthma using the asthma control questionnaire. Respir Med. 2006;100(4):616–621. doi:10.1016/j.rmed.2005.08.012
   PubMed Web of Science ®Google Scholar
• Cockroft DW, Swystun VA. Asthma control versus asthma severity. J Allergy Clin Immunol. 1996;98(6):1016–1018. doi:10.1016/S0091-6749(96)80185-0
   PubMed Web of Science ®Google Scholar
• Pavord ID, Jeffery PK, Qiu Y, et al. Airway inflammation in patients with asthma with high-fixed or low-fixed plus as-needed budesonide/formoterol. J Allergy Clin Immunol. 2009;123(5):1083–1089. doi:10.1016/j.jaci.2009.02.034
   PubMed Web of Science ®Google Scholar
• Rabe KF, Pizzichini E, Stallberg B, et al. Budesonide/formoterol in a single inhaler for maintenance and relief in mild-to-moderate asthma: a randomized, double-blind trial. Chest. 2006;129(2):246–256. doi:10.1378/chest.129.2.246
   PubMed Web of Science ®Google Scholar
• O’Byrne PM, Bisgaard H, Godard PP, et al. Budesonide/formoterol combination therapy as both maintenance and reliever medication in asthma. Am J Respir Crit Care Med. 2005;171(2):129–136. doi:10.1164/rccm.200407-884OC
   PubMed Web of Science ®Google Scholar
• Kuna P, Peters MJ, Manjra AI, et al. Effect of budesonide/formoterol maintenance and reliever therapy on asthma exacerbations. Int J Clin Pract. 2007;61(5):725–736. doi:10.1111/j.1742-1241.2007.01338.x
   PubMed Web of Science ®Google Scholar
• Brusselle G, Peché R, Van den Brande P, Verhulst A, Hollanders W, Bruhwyler J. Real-life effectiveness of extrafine beclometasone dipropionate/formoterol in adults with persistent asthma according to smoking status. Respir Med. 2012;106(6):811–819. doi:10.1016/j.rmed.2012.01.010
   PubMed Web of Science ®Google Scholar
• Paggiaro P. New pharmacologic perspectives in pneumology: beclomethasone-formoterol extrafine. Open Respir Med J. 2009;3(1):38–42. doi:10.2174/1874306400903010038
   PubMedGoogle Scholar
• Calzetta L, Matera MG, Facciolo F, et al. Beclomethasone dipropionate and formoterol fumarate synergistically interact in hyperresponsive medium bronchi and small airways. Respir Res. 2018;19(1):65. doi:10.1186/s12931-018-0770-7
   PubMed Web of Science ®Google Scholar
• Silverman SL. From randomized controlled trials to observational studies. Am J Med. 2009;122(2):114–120. doi:10.1016/j.amjmed.2008.09.030
   PubMed Web of Science ®Google Scholar
• Ware JH, Hamel MB. Pragmatic trials–guides to better patient care? N Engl J Med. 2011;364(18):1685–1687. doi:10.1056/NEJMp1103502
   PubMed Web of Science ®Google Scholar
• Muller V, Galffy G, Eszes N, et al. Asthma control in patients receiving inhaled corticosteroid and long-acting beta2-agonist fixed combinations. A real-life study comparing dry powder inhalers and a pressurized metered dose inhaler extrafine formulation. BMC Pulm Med. 2011;11(1):40. doi:10.1186/1471-2466-11-40
   PubMed Web of Science ®Google Scholar
• Allegra L, Cremonesi G, Girbino G, et al. Real-life prospective study on asthma control in Italy: cross-sectional phase results. Respir Med. 2012;106(2):205–214. doi:10.1016/j.rmed.2011.10.001
   PubMed Web of Science ®Google Scholar